V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260017028 | 260010044 | 1.55 | 66.6 | Palliative (P) | 2013-10-12 | 2014-02-28 | Cisplatin 7 day | 2 | N | 260010213 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260017029 | 260010045 | 1.78 | 76.4 | Curative (C) | 2018-08-21 | 2018-08-26 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260010318 | CISPLATIN + RT |
| 260017030 | 260010047 | null | 80.4 | Curative (C) | 2017-05-25 | 2017-09-13 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260010341 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260017031 | 260010050 | 1.88 | 91.5 | Adjuvant (A) | 2016-01-17 | 2016-01-18 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | N | N | 260010354 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260017032 | 260010051 | null | 57.8 | null | 2014-04-12 | 2014-05-10 | EP | N | N | 260010400 | IPO |
| 260017033 | 260010053 | 1.81 | 79 | Curative (C) | 2017-12-26 | 2017-12-27 | POMB | N | N | 260010422 | CARBO + THIOTEPA + TOPOTECAN |
| 260017034 | 260014760 | 1.69 | 97 | Disease modification (D) | 2016-04-19 | 2016-06-03 | Vinblastine weekly | 02 | N | 260010488 | CARBOPLATIN + ETOPOSIDE |
| 260017035 | 260014760 | null | 61 | Curative (C) | null | 2017-09-04 | NIVOLUMAB | null | null | 260010488 | DOCETAXEL |
| 260017036 | 260010057 | 1.64 | 62.6 | null | null | 2016-11-28 | BLEOMYCIN + VINCRISTINE | N | null | 260010561 | CHOP |
| 260017037 | 260010059 | null | null | Palliative (P) | 2016-06-01 | 2016-06-08 | Gemcitabine + Oxaliplatin | N | null | 260010563 | GEMCITABINE + TIP |
| 260017038 | 260014764 | 1.71 | 83.5 | Curative (C) | 2013-06-23 | 2014-08-23 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260010581 | GEMCITABINE + OXALIPLATIN |
| 260017039 | 260010063 | null | 65 | Curative (C) | 2015-10-03 | 2016-02-26 | CYCLOPHOSPHAMIDE | 02 | null | 260010628 | AXITINIB |
| 260017040 | 260014766 | 1.65 | 85.4 | Curative (C) | 2018-11-11 | 2018-11-12 | GEMCITABINE + OXALIPLATIN + PACLITAXEL | N | N | 260010646 | BLEOMYCIN + VINCRISTINE |
| 260017041 | 260010067 | 1.81 | 90 | Curative (C) | null | 2018-10-06 | Carboplatin + Etoposide IV 3 day | 2 | N | 260010651 | IPO |
| 260017042 | 260010070 | null | 89.3 | Disease modification (D) | null | 2016-08-25 | CYCLOPHOSPHAMIDE + VINORELBINE | N | N | 260010825 | PEMBROLIZUMAB |
| 260017043 | 260010073 | 1.73 | null | Not known (9) | 2016-09-02 | 2016-09-19 | BLEOMYCIN | N | null | 260010912 | PEMETREXED |
| 260017044 | 260010075 | 1.81 | 77.2 | Curative (C) | 2017-07-29 | 2017-08-03 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL | 2 | null | 260011034 | GEMCITABINE + OXALIPLATIN |
| 260017045 | 260017090 | 1.68 | 82 | Curative (C) | 2016-06-18 | 2016-06-19 | BLEOMYCIN + VINCRISTINE | 02 | N | 260011149 | BOP |
| 260017046 | 260010077 | 1.6 | 81 | Palliative (P) | 2014-06-21 | 2014-06-21 | CARBOPLATIN + ETOPOSIDE | N | N | 260011239 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260017047 | 260010080 | 1.8 | 96 | Adjuvant (A) | 2019-01-02 | 2019-01-02 | GEMCITABINE + TIP | N | N | 260011267 | RMS 2005 TRIAL |
| 260017048 | 260010081 | 1.65 | 51.4 | Curative (C) | 2015-11-20 | 2015-12-02 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | null | 260011404 | CARBOPLATIN + PEMETREXED |
| 260017049 | 260014776 | 1.62 | 46.6 | Not known (9) | 2015-06-20 | 2015-08-13 | Cisplatin 7 day | N | null | 260011412 | METHOTREXATE |
| 260017050 | 260010082 | 1.65 | 72.8 | Curative (C) | null | 2015-02-28 | Methotrexate High Dose (3g/m2) | N | N | 260011419 | IBRUTINIB |
| 260017051 | 260017093 | 1.83 | 112.2 | Palliative (P) | 2017-02-14 | 2017-03-20 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260011453 | BLEOMYCIN |
| 260017052 | 260010085 | 1.77 | 76.4 | Curative (C) | 2019-02-20 | 2019-02-20 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL | 02 | N | 260011488 | EP |
| 260017053 | 260010087 | 1.67 | 53 | Palliative (P) | 2015-07-15 | 2015-07-28 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | N | N | 260011685 | EP |
| 260017054 | 260019336 | 1.69 | 112.4 | null | null | 2019-06-21 | Carboplatin + Etoposide iv&po | N | N | 260011893 | BOP |
| 260017055 | 260010090 | 1.69 | 46.2 | Curative (C) | 2015-01-11 | 2015-01-13 | CISPLATIN + VINORELBINE + RT | 2 | N | 260011894 | LIPOSOMAL DOXORUBICIN |
| 260017056 | 260010093 | 1.8 | 68.8 | Disease modification (D) | 2017-01-28 | 2017-01-31 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260011938 | CYTARABINE + METHOTREXATE HD |
| 260017057 | 260010094 | null | null | Curative (C) | 2018-12-13 | 2018-12-27 | CYCLOPHOSPHAMIDE + VINORELBINE | N | N | 260011942 | POMB |
| 260017058 | 260010096 | 1.65 | 78.4 | Disease modification (D) | 2015-08-16 | 2016-03-03 | IVA | N | N | 260012022 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260017059 | 260010098 | 1.67 | 87.5 | Palliative (P) | null | 2013-06-24 | BLEOMYCIN + VINCRISTINE | N | N | 260012037 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260017060 | 260010098 | 1.73 | 59.15 | Palliative (P) | 2017-10-05 | 2017-12-08 | METHOTREXATE | 2 | N | 260012037 | ICE |
| 260017061 | 260010101 | 1.86 | 133.1 | Palliative (P) | 2017-01-19 | 2017-01-19 | EP | 2 | N | 260012314 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260017062 | 260010107 | 1.67 | 55.6 | Palliative (P) | null | 2018-07-30 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | Y | 260012546 | IFOSFAMIDE + PACLITAXEL |
| 260017063 | 260010110 | 1.77 | 73.8 | Disease modification (D) | null | 2016-03-25 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260012648 | CARBOPLATIN + ETOPOSIDE |
| 260017064 | 260014793 | 1.66 | 79 | Disease modification (D) | 2017-11-17 | 2017-11-17 | Cyclophosphamide High Dose | N | null | 260012721 | CARBOPLATIN + ETOPOSIDE |
| 260017065 | 260010116 | 0 | 95 | Curative (C) | 2018-02-12 | 2018-02-12 | BOP | 02 | N | 260013480 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260017066 | 260010118 | 1.7 | null | Curative (C) | 2015-09-13 | 2015-09-13 | Cyclophosphamide High Dose | 02 | N | 260014167 | CHOP |
| 260017067 | 260019265 | 1.85 | 68.8 | Curative (C) | 2018-01-03 | 2018-01-15 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | Y | 260014167 | VEIP |
| 260017068 | 260014796 | 1.65 | 73 | Curative (C) | 2013-06-30 | 2013-07-07 | GEMCITABINE + TIP | N | N | 260014651 | EP |
| 260017069 | 260010122 | 1.76 | 87 | Palliative (P) | 2019-09-11 | 2019-09-11 | CISPLATIN + EPIRUBICIN | 02 | null | 260014883 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260017070 | 260010124 | 1.88 | 57.3 | Radical (R) | null | 2016-07-23 | IPO | N | N | 260014992 | CARBO + THIOTEPA + TOPOTECAN |
| 260017071 | 260010124 | 1.81 | 95.8 | Palliative (P) | 2014-06-13 | 2014-06-20 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260014992 | IVA |
| 260017072 | 260010126 | 1.73 | 67.8 | Palliative (P) | 2014-11-08 | 2014-11-14 | GEMCARBO | N | N | 260015755 | GEMCITABINE + OXALIPLATIN |
| 260017073 | 260010128 | 1.65 | 78.2 | Adjuvant (A) | 2015-07-24 | 2017-03-29 | Cyclophosphamide High Dose | null | null | 260015858 | LIPOSOMAL DOXORUBICIN |
| 260017074 | 260010129 | 1.82 | 106.5 | Palliative (P) | 2019-01-17 | 2019-03-19 | IFOSFAMIDE + PACLITAXEL | 2 | N | 260016002 | IFOSFAMIDE + PACLITAXEL |
| 260017075 | 260010130 | 1.8 | 85.4 | Adjuvant (A) | 2018-10-24 | 2018-10-24 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | 260016020 | POMB/ACE |
| 260017076 | 260010134 | 1.91 | 76.4 | Disease modification (D) | 2016-12-02 | 2016-12-07 | CARBO + THIOTEPA + TOPOTECAN | 2 | N | 260016240 | RCEOP |
| 260017077 | 260018830 | 1.63 | 65.4 | Disease modification (D) | 2015-04-15 | 2015-04-22 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 260016432 | FEC |